Literature DB >> 6262556

Endocrine responsiveness in human melanocytes and melanoma cells in culture.

B B Fuller, F L Meyskens.   

Abstract

Studies were performed for the investigation of endocrine responsiveness in cell lines derived from either normal human melanocytes or human melanoma cells. Alterations in differentiation (tyrosinase activity) were determined in cells exposed to either melanocyte-stimulating hormone (MSH, 10(-7) M), theophylline (10(-3) M), N6,O2'-dibutyryl cyclic AMP (db-cAMP, 10(-4) M), or prostaglandin E1 (PGE1, 10(-6) M). Cultures derived from normal uveal melanocytes demonstrated increased tyrosinase activity upon exposure to either theophylline, db-cAMP, or PGE1, but not to MSH. However, MSH responsiveness was detected in 7 of 11 human melanoma cell lines. Four cell lines demonstrated increased activity of tyrosinase after MSH treatment, whereas three lines showed an MSH-induced inhibition of enzyme activity. PGE1 was effective in stimulating tyrosinase activity in five of nine cell lines examined. Theophylline was the most effective stimulator of tyrosinase in melanoma-derived cell populations and caused increased enzyme activity in eight of eleven cell lines.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6262556

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Hormonal stimulation of tyrosinase activity in human foreskin organ cultures.

Authors:  M Iwata; S Iwata; M A Everett; B B Fuller
Journal:  In Vitro Cell Dev Biol       Date:  1990-06

Review 2.  MC1R, the cAMP pathway, and the response to solar UV: extending the horizon beyond pigmentation.

Authors:  Jose C García-Borrón; Zalfa Abdel-Malek; Celia Jiménez-Cervantes
Journal:  Pigment Cell Melanoma Res       Date:  2014-05-30       Impact factor: 4.693

3.  A unique gender difference in early onset melanoma implies that in addition to ultraviolet light exposure other causative factors are important.

Authors:  Feng Liu; Leona Bessonova; Thomas H Taylor; Argyrios Ziogas; Frank L Meyskens; Hoda Anton-Culver
Journal:  Pigment Cell Melanoma Res       Date:  2012-11-21       Impact factor: 4.693

4.  Melanotropin receptors demonstrated in situ in human melanoma.

Authors:  J B Tatro; M Atkins; J W Mier; S Hardarson; H Wolfe; T Smith; M L Entwistle; S Reichlin
Journal:  J Clin Invest       Date:  1990-06       Impact factor: 14.808

Review 5.  Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment.

Authors:  R Radinsky
Journal:  Cancer Metastasis Rev       Date:  1995-12       Impact factor: 9.264

6.  Enhancement of pulmonary metastasis formation and gamma-glutamyltranspeptidase activity in B16 melanoma induced by differentiation in vitro.

Authors:  J A Prezioso; N Wang; L Duty; W D Bloomer; E Gorelik
Journal:  Clin Exp Metastasis       Date:  1993-05       Impact factor: 5.150

7.  NK-mediated reduction of malignancy in human melanoma cells treated with theophylline.

Authors:  I Gitelman; W Abramow-Newerly; J C Roder
Journal:  Clin Exp Metastasis       Date:  1987 Oct-Dec       Impact factor: 5.150

Review 8.  Growth factors in melanoma.

Authors:  U Rodeck; M Herlyn
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

Review 9.  Mechanisms of differentiation in melanoma cells and melanocytes.

Authors:  D C Bennett
Journal:  Environ Health Perspect       Date:  1989-03       Impact factor: 9.031

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.